Search

everythinglearnresearchcommunity

for

Search:↓

TIP39 and PTH2R help control calcium levels and skin cell development.

Cognitive-behavioral therapy is the best treatment for hair-pulling disorder, and combining it with other therapies could improve results.

Most cases of Temporal Triangular Alopecia are found in early childhood and may be related to genetic conditions.

A woman with Hashimoto's hypothyroidism developed Graves' hyperthyroidism after 20 years, showing these conditions may be linked.

Traditional Persian medicine helped a woman with resistant hyperthyroidism improve and stabilize her condition.

Low iron and vitamin D3 levels might be major causes of hair loss in Iraqi women.

A specific gene mutation causes sparse, brittle hair in a family.

Women have a higher DHT/testosterone ratio than men, possibly due to gut bacteria activity.

Mutations in TBX3 cause horses to have more even hair color instead of Dun camouflage.

Different hair fiber development might explain why hair loss severity varies in patients with a specific genetic mutation, and treatments that thicken hair could help.

A rare case of trichothiodystrophy was found with autism, seizures, and mental retardation.

Temporary scalp trichopigmentation creates a shaved hair look on the scalp using pigments that fade over time.

Lower DHT and higher testosterone levels increase brain activation but don't change behavior in heavy drinkers.

Many patients with hair loss had low iron and vitamin D levels, but thyroid issues were not common.

The conclusion is that the variation in hair thinness in patients is mostly due to the amount of underdeveloped hairs, and treatments that thicken fine hairs might work for those with mild to severe conditions.

The hamster polyomavirus middle T antigen is linked to tumors in hamsters and associates with a specific tyrosine kinase.

The mutation causes hairless mice due to mislocalized and dysfunctional HR protein.

Hair transplant surgery effectively treated a specific type of hair loss and is recommended as a primary treatment option.

People with both obvious and not-so-obvious underactive thyroid issues often have higher levels of the hormone prolactin.

Tetrathiomolybdate reduces hair growth marker in skin cells by boosting harmful oxygen molecules, but effects can be reversed.

Vitamin D receptor can control the hairless gene linked to hair loss even without vitamin D.

A substance called compound-1 could help increase hair growth by maintaining prostaglandin levels in hair follicles.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Birt–Hogg–Dubé syndrome is a rare genetic condition causing skin lesions, lung cysts, and a higher chance of kidney cancer.

Diode laser treatment works better for facial hirsutism in patients with normal hormone levels.

Some drugs may cause hair loss in women.

The new composite scaffold may effectively treat chronic and deep wounds.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.